Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Sodium aurothiomalate
Drug ID BADD_D02033
Description Sodium aurothiomalate is a gold compound that is used for its immunosuppressive anti-rheumatic effects. Gold Sodium Thiomalate is supplied as a solution for intramuscular injection containing 50 mg of Gold Sodium Thiomalate per mL. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis.
Indications and Usage As anti-inflammatory agent for the treatment of arthritis. Disease-modifying antirheumatic drug, DMARD.
Marketing Status Not Available
ATC Code M01CB01
DrugBank ID DB09276
KEGG ID D00992
MeSH ID D006052
PubChem ID 22318
TTD Drug ID D0FH7C
NDC Product Code Not Available
Synonyms Gold Sodium Thiomalate | Sodium Thiomalate, Gold | Sodium Aurothiomalate | Aurothiomalate, Sodium | Mercaptobutanedioic Acid Monogold(1+) Sodium Salt | Sodium Gold Thiomalate | Gold Thiomalate, Sodium | Sodium Thiomalatoaurate | Thiomalatoaurate, Sodium | Gold Disodium Thiomalate, Monohydrate | Gold Thiomalate | Thiomalate, Gold | Gold Thiomalic Acid | Aurolate | Monogold (1+) Disodium Thiomalate | Myochrysine | Myocrisin | Miocrisin | Myocrysine | Tauredon | Aurothiomalate | Miocrin
Chemical Information
Molecular Formula C4H3AuNa2O4S
CAS Registry Number 12244-57-4
SMILES C(C(C(=O)[O-])[S-])C(=O)[O-].[Na+].[Na+].[Au+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.002--
Agranulocytosis01.02.03.001--Not Available
Albuminuria20.02.01.001--Not Available
Alopecia23.02.02.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Aplastic anaemia01.03.03.002--Not Available
Arthralgia15.01.02.001--
Asthenia08.01.01.001--Not Available
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.002--Not Available
Bronchitis22.07.01.001; 11.01.09.001--
Colitis ulcerative10.02.01.004; 07.08.01.005--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Conjunctivitis06.04.01.002; 11.01.06.012--
Deposit eye06.09.04.005--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Diarrhoea07.02.01.001--
Dizziness02.01.02.004; 24.06.02.007; 17.02.05.003--
Dysgeusia17.02.07.003; 07.14.03.001--
Dysphagia07.01.06.003--
Dyspnoea22.02.01.004; 02.01.03.002--
Eczema23.03.04.006--
Encephalitis17.06.05.001; 11.01.03.008--
Encephalopathy17.13.02.001--
Enterocolitis07.08.03.003--
Eosinophilia01.02.04.001--
The 1th Page    1 2 3    Next   Last    Total 3 Pages